Use of a DNA sequencing method called peptide nucleic acid fluorescence in-situ hybridization in ICU patients with enterococcus or streptococcus bloodstream infections reduced their mortality rate by nearly 50% and cut mortality from yeast infections by 86%, according to a study conducted by researchers at the University of Arizona. The method also led to reductions in health care costs by about $5 million annually, the researchers said.

Full Story:
BioOptics World

Related Summaries